The Sweet Syndrome during Therapy with Granulocyte Colony-stimulating Factor

Brief Reports15 June 1992The Sweet Syndrome during Therapy with Granulocyte Colony-stimulating FactorJohn W. Park, MD, Bhoomi Mehrotra, MD, Bryan O. Barnett, MD, Ari D. Baron, MD, Alan P. Venook, MDJohn W. Park, MD, Bhoomi Mehrotra, MD, Bryan O. Barnett, MD, Ari D. Baron, MD, Alan P. Venook, MDAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-116-12-996 SectionsAboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail ExcerptGranulocyte colony-stimulating factor (G-CSF; filgrastim), a hematopoietic growth factor that promotes the proliferation and differentiation of neutrophils, is an important new adjunct to cancer chemotherapy. It is effective in lessening the degree and duration of neutropenia and is usually well tolerated. We report a case of the Sweet syndrome that developed during G-CSF therapy in a woman with breast cancer who was undergoing chemotherapy.Case ReportA 41-year-old woman receiving chemotherapy and G-CSF therapy for breast cancer presented with acute fever and skin rash. Except for recently diagnosed breast cancer, her medical history was unremarkable. The diagnosis of breast cancer...References1. Sweet R. An acute febrile neutrophilic dermatosis. Br J Dermatol. 1864;76:349-56. CrossrefGoogle Scholar2. KemmettHunter DJ. Sweet's syndrome: a clinicopathologic review of twenty-nine cases. J Am Acad Dermatol. 1990;23:503-7. CrossrefMedlineGoogle Scholar3. CohenTalpazKurzrock PMR. Malignancy-associated Sweet's syndrome: review of the world literature. J Clin Oncol. 1988;6:1887-97. CrossrefMedlineGoogle Scholar4. CohenKurzrock PR. Sweet's syndrome and malignancy. Am J Med. 1987;82:1220-6. CrossrefMedlineGoogle Scholar5. MeuldersAllalEggersFerrant QASA. Sweet's syndrome and myelodysplastia syndrome in a patient with metastatic breast carcinoma. Am J Med. 1989;86:138-9. CrossrefMedlineGoogle Scholar6. WakefieldJamesSamlaskaMeltzer PWCM. Colony-stimulating factors. J Am Acad Dermatol. 1990;23:903-12. CrossrefMedlineGoogle Scholar7. GlaspyBaldwinRobertsonSouzaVincentAmbersley JGPLMJ. Therapy for neutropenia in hairy cell leukemia with recombinant human granulocyte colony-stimulating factor. Ann Intern Med. 1988;109:789-95. LinkGoogle Scholar8. CohenKurzrock PR. Diagnosing the Sweet syndrome [Letter]. Ann Intern Med. 1989;110:573-4. LinkGoogle Scholar9. NegrinHaenberNaglerOldsDonlonSouza RDALTL. Treatment of myelodysplastic syndromes with recombinant human granulocyte colony-stimulating factor. Ann Intern Med. 1989;110:976-84. LinkGoogle Scholar10. RossMoyKaplanFiglin HLRR. Bullous pyoderma gangrenosum after granulocyte colony-stimulating factor treatment. Cancer. 1991;68:441-3. CrossrefMedlineGoogle Scholar11. DreicerSchillerCarbone RJP. Granulocyte-macrophage colony-stimulating factor and vasculitis [Letter]. Ann Intern Med. 1989;111:91-2. LinkGoogle Scholar This content is PDF only. To continue reading please click on the PDF icon. Author, Article, and Disclosure InformationAuthors: John W. Park, MD; Bhoomi Mehrotra, MD; Bryan O. Barnett, MD; Ari D. Baron, MD; Alan P. Venook, MDAffiliations: From the University of California, San Francisco, San Francisco, California. For current author addresses, see end of text. PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics Cited byNeutrophilic Dermatosis and Management Strategies for the Inpatient DermatologistNeutrophilic Dermatoses: a Clinical UpdateSweet's syndrome associated with hematological malignanciesManagement of chemotherapy-induced neutropenia in patients with cancer: 2019 guidelines of the Italian Medical Oncology Association (AIOM)Insights Into the Pathogenesis of Sweet's SyndromeNeutrophilic dermatosesIsolated abdominal aortitis following administration of granulocyte colony stimulating factor (G-CSF)Sweet Syndrome: A Review and UpdateSweet Syndrome: A Review and UpdateChildhood Sweet SyndromeGranulocyte–macrophage colony-stimulating factor (GM-CSF)Sweet Syndrome and Its Association with Hematopoietic NeoplasmsCutaneous Findings in Hemophagocytic LymphohistiocytosisCase of vemurafenib-induced Sweet's syndromeSweet's syndrome: A revisit for hematologists and oncologistsManifestaciones cutáneas de las hemopatías malignasManifestations cutanées des hémopathies malignesManifestaciones cutáneas de las hemopatías malignasManifestations cutanées des hémopathies malignesCutaneous adverse reactions to drugsKapitel E1 Literaturverzeichnis zu Peter, Pichler, Müller-Ladner (Hrsg.): Klinische ImmunologieSkin Disorders Difficult to Distinguish from InfectionVasculitis, Neutrophilic Dermatoses and Related DisordersSweet's syndrome with neurologic manifestations in a patient with esophageal adenocarcinoma: case report and review of the literaturePediatric Sweet Syndrome: Case Report and Literature ReviewSweet Syndrome Associated With Granulocyte Colony-Stimulating FactorLongitudinal Analysis of Cytokines and Chemokines in the Cerebrospinal Fluid of a Patient with Neuro-Sweet Disease Presenting with Recurrent EncephalomeningitisSweet's syndrome – a comprehensive review of an acute febrile neutrophilic dermatosisInfiltration lymphocytaire dermique précédant un syndrome de SweetDrug-Induced Sweet's SyndromeSConcurrent occurrence of Sweet's syndrome and erythema nodosum: an overlap in the spectrum of reactive dermatosesManifestations cutanées des leucémiesNeutropénies constitutionnelles et acquisesManifestations cutanées des hémopathies malignesNeutropénies constitutionnelles et acquisesBullous Sweet's syndrome in congenital neutropenia: Association with pegfilgrastimCrohn's Disease Associated with Sweet's Syndrome and Sjögren's Syndrome Treated with InfliximabSweet's syndrome associated with sargramostim (granulocyte-macrophage colony stimulating factor) treatmentNeutrophil-dependent cutaneous side-effects of leucocyte colony-stimulating factors: manifestations of a neutrophil recovery syndrome?The coexistence of Sweet's syndrome and Still's disease—is it merely a coincidence?Manifestations cutanées des leucémiesSíndrome de Sweet y enfermedad sistémicaManifestaciones cutáneas de las leucemiasSweet's syndrome revisited: a review of disease conceptsDrug-induced Sweet's syndrome in acne caused by different tetracyclines: case report and review of the literatureSweet Syndrome in InfantsSweet??s SyndromeNeutrophilic Dermatoses in Two Children with Idiopathic Neutropenia: Association with Granulocyte Colony‐Stimulating Factor (G‐CSF) TherapySweet`s syndrome during the treatment of acute promyelocytic leukemia with all - trans retinoic acidComparative Safety of Filgrastim versus Sargramostim in Patients Receiving Myelosuppressive ChemotherapySweet's syndrome: a neutrophilic dermatosis classically associated with acute onset and feverA Cutaneous Eruption from G-CSF in a Healthy DonorAll-trans-retinoic acid-induced myositis: A description of two patientsSweet's syndrome accompanying leukaemia: seven cases and review of the literatureCase of granulocyte colony-stimulating factor-induced Sweet's syndromeDiagnostic approach to patients with cholestatic jaundiceHistopathology of cutaneous reaction to granulocyte colony-stimulating factor: another pseudomalignancyNeutrophilic eccrine hidradenitis induced by granulocyte colony-stimulating factorClinicopathology conferences: Inflammation-induced cholestasisRepeated Cycles of G‐CSF‐Combined Postremission Chemotherapy for Acute Myeloid Leukemia in a First Complete Remission: A Pilot StudySweet's syndrome associated with non-tuberculous mycobacterial infection: a report of five casesNeutrophilic Dermatosis Occurring in a Patient with Aplastic Anemia during Human Granulocyte Colony-Stimulating Factor Therapy.Histologically Distinctive Papular Neutrophilic Xanthomas in HIV-1+ PatientsBullous Pyoderma Gangrenosum in a Patient with Myelodysplastic Syndrome During Granulocyte Colony-Stimulating Factor TherapySweet's syndrome secondary to granulocyte colony-stimulating factorReplyAdverse cutaneous reactions to chemotherapeutic agents and cytokine therapySweet's syndrome induced by granulocyte colony-stimulating factor in a woman with congenital neutropeniaCytokinesRecurrent exacerbation of acne by granulocyte colony-stimulating factor administrationTrimethoprim-sulfamethoxazole-associated acute febrile neutrophilic dermatosis: Case report and review of drug-induced Sweet's syndromeSkin lesions and G-CSF in patients with malignant diseases. Malignancy or cutaneous side-effect?Lymphoedema-area-restricted Sweet syndrome during G-CSF treatmentA generalized cutaneous reaction induced by granulocyte colony-stimulating factorSWEET'S SYNDROMENeutrophilic Dermatosis Associated with Myelodysplastic Syndrome.Sweet's syndrome during acute myeloid leukaemia: Is there a role for hematopoietic growth factors?Cutaneous reactions to recombinant cytokine therapyUnusual cutaneous manifestations of myelodysplastic syndromeReactivation of rheumatoid arthritis and development of leukocytoclastic vasculitis in a patient receiving granulocyte colony-stimulating factor for felty's syndromeDermatose neutrophilique aiguë fébrile pustuleuse et bulleuse (syndrome de Sweet) révélant une leucémie aiguë myéloblastiqueDisseminated intravascular coagulation associated with granulocyte colony-stimulating factor therapy in a child with human immunodeficiency virus infectionTransformation of congenital neutropenia into monosomy 7 and acute nonlymphoblastic leukemia in a child treated with granulocyte colony-stimulating factorSweet's Syndrome Associated with Cerebrospinal Fluid Neutrophilic PleocytosisErythema nodosum caused by the administration of granulocyte colony-stimulating factor in a patient with refractory anemiaIndication for and caution in the use of granulocyte colony-stimulating factor for the treatment of Felty's syndrome: comment on the report by Yasuda et a1Sweet's syndrome (acute febrile neutrophilic dermatosis)Sweet Syndrome as the Presenting Manifestation of Chronic Granulomatous Disease in an InfantSWEET'S SYNDROME: CLINICOPATHOLOGIC STUDY OF ELEVEN CASESSubcorneal pustular dermatosis at the injection site of recombinant human granulocyte-macrophage colony-stimulating factor in a patient with IgA myelomaCutaneous drug reactionsSweet's syndrome during therapy with granulocyte colony-stimulating factor in a patient with aplastic anaemiaAcute neutrophilic dermatosis with myeloblastic infiltrate in a leukemia patient receiving all-trans-retnoic acid therapySweet's syndrome in myeloid malignancy: a report of two casesThe Possible Role of G-CSF in the Pathogenesis of Sweet's SyndromeSweet's syndrome associated with G-CSFSequential administration of cyclophosphamide and granulocyte-colony stimulating factor relieves impaired myeloid maturation in felty's syndromeSweet's syndrome associated with myelodysplasia: possible role of cytokines in the pathogenesis of the diseaseSouthwestern Internal Medicine Conference: Clinical Use of Hematopoietic Growth FactorsHematopoietic growth factors in rheumatoid arthritis: A critical approach to their use in view of possible adverse effectsBlood, blood components, plasma and plasma productsThe Sweet Syndrome or G-CSF Reaction?Debra Lynn Karp, MDGranulocyte colony-stimulating factorCytokines and biological response modifiers in the treatment of infection 15 June 1992Volume 116, Issue 12_Part_1Page: 996-998KeywordsBreast cancerChemotherapyFeversGranulocyte colony stimulating factorHematology and oncologyHematopoietic growth factorsHyperthermiaNeutropeniaNeutrophilsRashes ePublished: 1 December 2008 Issue Published: 15 June 1992 PDF downloadLoading ...